Foundations

For most of medical history, "living longer" meant pushing back the moment of death. The infectious-disease era closed; the chronic-disease era opened; and a strange gap grew between how long people live and how long they live well. WHO data from 183 member states put the average healthspan-lifespan gap at 9.6 years, with the United States at 12.4 years and women carrying a 2.4-year-larger gap than men.^[1] Nearly a decade of accumulated disability is now the default end-of-life experience for the average adult in a developed country.

Geroscience is the response: a research programme that treats biological aging itself as the primary risk factor for the diseases that fill that gap — cardiovascular, neurodegenerative, oncologic, metabolic — rather than treating each one as an isolated silo.^[2] If the underlying mechanisms of aging can be slowed, multiple morbidities are slowed at once. This pillar collects the conceptual scaffolding the rest of the site is built on.

Healthspan vs. lifespan

Two terms, often blurred:

• Lifespan — chronological duration of life
• Healthspan — the years lived free of chronic disease, cognitive decline, and functional disability

The stated goal of modern longevity work is to compress morbidity — narrow the gap so the period of dependence at the end of life is short. This reframes most interventions on this site. Their value is not in pushing back the moment of death, but in pushing back the moment when disease begins to dominate everyday function. A diet, a training programme, or a screening cadence that buys five more good years before the first chronic diagnosis is doing more than a drug that adds five more years at the tail end.

What aging is, biologically

The dominant framework is the Hallmarks of Aging — originally nine processes (López-Otín et al., Cell 2013), expanded to twelve in 2023.^[3] The twelve are organized into three tiers: primary hallmarks (root cellular damage — genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy); antagonistic hallmarks (compensatory responses that turn maladaptive — deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence); and integrative hallmarks (the systemic phenotype — stem cell exhaustion, altered intercellular communication, chronic inflammation, dysbiosis). They are densely networked: telomere attrition can trigger senescence, which drives inflammation, which accelerates epigenetic drift, which feeds back upstream. The framework is the theoretical basis for nearly every "anti-aging" intervention worth taking seriously; the full picture lives under Hallmarks of aging.

A parallel "Hallmarks of Health" framework adds a ninth dimension that traditional biology kept separate: psychosocial adaptation.^[4] Loneliness, chronic stress, and lack of purpose are not soft factors — they deregulate the immune system, accelerate epigenetic clocks, and produce mortality hazards comparable to obesity or smoking. The depth on this lives under Purpose.

Inherited vs. modifiable

Inherited DNA sequence variants account for an estimated 15–25% of lifespan variance. The remaining 75–85% is dictated by environmental and behavioural inputs continuously codified in the epigenome. This is why behaviour dominates the practical advice on this site: even an unfavourable genetic hand (APOE ε4 for Alzheimer's, for example) leaves the modifiable factors with their effect sizes intact — often more relevant, because the absolute risk is higher.

The 75–85% non-genetic share has two large components. One is lifestyle — what you eat, how you move, how you sleep, who you spend time with. The other is the exposome — the cumulative non-genetic input from air, water, household chemicals, and psychosocial stress. Specific chemicals (cadmium, lead, phthalates, bisphenols, PFAS) measurably accelerate epigenetic-aging clocks at population scale; substitution interventions can drop urinary biomarkers within days. See Environmental toxins.

A related, often-overlooked input is the mouth. The oral-systemic axis links periodontitis to atherosclerosis and the Alzheimer's brain; tongue bacteria are the body's main source of nitric oxide once endothelial production falls off in midlife. The intervention list is short, cheap, and unusually well-evidenced — see Oral health. The single largest preventable-mortality lever in modern medicine sits alongside it: combustible tobacco, complicated by the spread of non-combustible nicotine. See Smoking and nicotine.

Measuring biological age

Chronological age is the worst available proxy for how an individual is actually aging — two 50-year-olds can be biologically a decade apart. The frontier of geroscience is the development of biomarkers that read the rate of decay directly.

Epigenetic clocks read DNA methylation patterns at specific CpG sites across the genome.

• First-generation clocks (Horvath, Hannum) were trained against chronological age and are useful but blunt instruments for predicting outcomes.
• GrimAge, a second-generation clock, was trained against lifespan and healthspan directly — it consistently outperforms its predecessors and telomere-length measurements for predicting all-cause mortality.^[5]
• DunedinPACE is a third-generation clock that does not estimate an absolute age. Instead it measures the rate of aging — a speedometer rather than an odometer — and is uniquely sensitive to short-term lifestyle change, which makes it the leading tool for evaluating intervention effects.^[6]

Heart rate variability (HRV) — the millisecond fluctuation between heartbeats — is a non-invasive, continuously-trackable read on autonomic regulation that declines monotonically with age and tracks systemic inflammation, metabolic dysfunction, and resilience. Modern wearables can capture it every night, with real caveats about which devices actually do it well. The full picture lives under Heart rate variability.

Resting heart rate (RHR) is the cheapest and most-replicated of all. Pooled data on over 500,000 individuals shows every 10 bpm rise in RHR carries a ~20% higher hazard for all-cause mortality; adults with an RHR below 60 bpm have a mean survival of about 79 years, compared with about 70 years above 90 bpm.^[7]

Single-cell sequencing and AI-derived "tissue aging clocks" are extending these tools to specific cell populations — useful for research, not yet routine in clinic.

The behavioural hierarchy

The interventions that move biological-age biomarkers in healthy adults are stubbornly the same ones that move hard cardiovascular and mortality endpoints. The American Heart Association consolidated them in 2022 as Life's Essential 8: diet, physical activity, nicotine avoidance, sleep, body mass index, blood lipids, blood glucose, blood pressure.^[8] Adults in the highest LE8 score band have roughly half the all-cause mortality and 30% the cardiovascular mortality of those in the lowest, with the relationship continuous across the 0–100 scale.

A reasonable mental hierarchy for healthy midlife adults:

1. Cardiorespiratory fitness and muscular strength. Each 1-MET increase in fitness is associated with an 11–17% reduction in all-cause mortality, and the combination of high fitness and high strength delivers larger effects than either alone — substantially larger than any pharmacological geroprotector currently in human trials.
2. A vegetable- and fish-heavy dietary pattern (Mediterranean, MIND), optionally paired with time-restricted eating in a window that ends before late evening.
3. Sleep regularity — at least as predictive of mortality as duration, and possibly more so. UK Biobank accelerometer data on 60,000+ adults show the most regular sleepers have 20–48% lower all-cause mortality than the least regular.
4. Controlled hormetic stressors — frequent sauna at high temperatures has the strongest mortality cohort signal of any "wellness" intervention. Cold and brief intense exercise have weaker but real effects.
5. Social connection and a maintained sense of purpose. Effect sizes here hold up against most physical-health interventions.
6. Reduce exposome load — air filtration, decent water filtration, no synthetic fragrance, glass and steel out of food contact.

Each of these has a dedicated pillar on the site. The pharmacological frontier — metformin (TAME), rapamycin (PEARL), senolytics, NAD⁺ precursors, partial reprogramming — is genuinely interesting and currently below the line of routine recommendation for healthy adults; it is covered under Geroprotectors and Clinical Care.

A separate, often-cited line of evidence — the Blue Zones — claims that a handful of geographically distinct populations (Sardinia, Okinawa, Nicoya, Ikaria, Loma Linda) reach exceptional ages on shared behavioural patterns. Some of the demographic claims have been challenged, but the behavioural commonalities replicate well in independent cohorts. See Blue Zones for what the data does and doesn't say. The integrative biology of the gut, liver, and metabolism that ties many of these patterns together is covered under Bile and metabolism.

How to evaluate a "longevity intervention"

Most of what circulates as longevity advice is mechanistic plausibility dressed as clinical evidence. A short filter for reading any new claim:

1. What's the evidence type?

   • Animal data only → very weak human applicability
   • Surrogate biomarker change in humans → suggestive but unproven
   • RCT with a hard endpoint → the gold standard
   • Mendelian randomization → strong causal inference, frequently deflates observational claims

2. Who funded the study? Industry-funded longevity supplement trials systematically over-report positives.

3. Is the population relevant? A signal in 80-year-olds with sarcopenia may not generalize to a healthy 45-year-old.

4. What's the absolute effect size? A "30% relative risk reduction" of a rare event is small absolutely. Lifestyle interventions usually beat supplements on absolute terms.

5. What's the alternative? Sometimes the best intervention is removing a harm (smoking, ultra-processed food, untreated sleep apnea), not adding a new one.

---